
What We Know about Artificial Food Dyes and Health as RFK, Jr., Declares a U.S. Ban
The move by Kennedy, the Trump administration's secretary of the Department of Health and Human Services, follows his earlier promises to ban various chemical food additives—including artificial colorings that are commonly used to brighten rainbow-colored cereals, pastries, chips, candies and other processed foods. Individual states, such as California and West Virginia, have also independently pushed legislation to ban certain food dyes and preservatives this year. At today's press event, Kennedy discussed the directive and various claims about the nutritional value of foods alongside Food and Drug Administration director Marty Makary, National Institutes of Health director Jay Bhattacharya and other public officials. Makary said they will establish a timeline for the food industry transition to 'natural alternatives.'
'There's no reason not to remove [such artificial food dyes] if they're there just for visual appeal. If there's no health-promoting purpose, and there's actually even the slightest risk of detriments to health, then why not remove them?' says Kathleen Melanson, a nutritional scientist at the University of Rhode Island. She adds, however, that these chemical dyes are likely only part of the problem. 'There's so much more to food than single factors,' Melanson says.
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
What It Means
The FDA currently certifies nine color additives for use in foods. By this past January the outgoing Biden administration had already started the process to ban one of them, Red No. 3. Kennedy will target the other eight artificial food dyes, such as Yellow No. 5, Blue No. 1 and Red No. 40.
The decision to ban Red No. 3 was based on a study in which male rats developed thyroid tumors after being exposed to high levels of the substance. Even though other studies in humans and animals failed to show similar results, the dye was banned under the Federal Food, Drug and Cosmetics Act's Delaney Clause, explains Tracy Crane, an associate professor of medical oncology at the Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine and the University of Miami Health System.
'In the Delaney Clause, [proponents of the ban] were able to state that anything that caused cancer in humans or animals could be eliminated from the diet, and that's what happened with Red No. 3,' says Crane, who had wondered if other food dyes would experience the same fate. 'There are definitely studies for some of these [dyes] that are on the list that have shown cancer-causing properties in mice.'
What the Evidence Says
Older animal studies have associated some blue, yellow and red dyes with risks of tumor development and neurotoxicity. Some research suggests the neurotoxicity may contribute to attention deficit hyperactivity disorder. Melanson calls the evidence 'mixed,' however. Direct exposure has only been tested in animals. Human data have been mostly limited to population or epidemiological studies—in which participants have been asked to recall and self-report the foods they've eaten. This has led some scientists to say there is not enough information to make conclusions about food dyes' potential health threats.
An FDA research review on food dyes' potential effects on children's behavior also concluded that most children didn't experience adverse effects, though some individuals may be sensitive to some dyes. The FDA states that color additives are safe to consume when they are used according to the agency's regulations. And the International Association of Color Manufacturers, a group representing the global color industry, has previously said that the small levels of artificial food dyes that humans typically eat are generally safe. (At press time, the association has not responded to a request for comment from Scientific American.)
'The danger is always in the dose,' Melanson says.
A Wall Street Journal analysis evaluated U.S. Department of Agriculture data for more than 450,000 food products and found that 10 percent contained at least one artificial dye—and that more than 40 percent had multiple dyes. 'When food additives are approved, they're generally tested one at a time,' Melanson says. 'We don't know what happens with interactions.'
Consuming a food with multiple dyes makes it difficult to know the total dose that has been ingested, Melanson says. The accumulative effects of a whole diet comprised of many different foods with artificial dyes, consumed over a lifetime, is even harder to assess. A disease like cancer takes a long time develop, Crane says, noting, 'It's very hard for us to really know what the direct impact of these food diets is.' She adds that not all the dyes are made the same and each may be processed in the body differently.
Melanson and Crane agree that food dyes are just one ingredient that may contribute to health risks.
'It's not just about one type of ingredients; it's about every ingredient that's in there,' Melanson says. 'If it's all tunnel vision on one factor without considering these other potential risk factors—the excess of sodium and sugar and processing, lack of fiber, lack of fortifying nutrients—then we might be missing some aspects.'
More details are pending, but it's expected that food manufacturers may have to alter their production practices or consider alternative coloring additives. Natural, food-based sources such as turmeric, paprika, pumpkin or carrot have been used as well. But it's unclear what the transition will cost manufacturers and federal agencies, Melanson says. Currently, manufacturers have until 2027 to remove Red No. 3 from food products and until 2028 to remove it from medicines. At today's press briefing, however, RFK, Jr., and other health officials asserted that this dye and the others need to be removed sooner, though no official timeline was presented.
'I know these procedures take time, and food manufacturers have to reformulate,' Melanson says. 'But in the meantime, Americans can consider backing off ultraprocessed foods—the ones that are obviously at the high end of the spectrum of processing and formulation.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
26 minutes ago
- Business Wire
Marea Therapeutics Enrolls First Participant in Phase 1 Clinical Study Evaluating MAR002 for Acromegaly
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced that the first participant has been enrolled in Marea's Phase 1 study evaluating MAR002 for the treatment of acromegaly. Acromegaly is a chronic, rare, systemic disease most often caused by a growth hormone (GH)-secreting pituitary adenoma, leading to the overproduction of insulin-like growth factor 1 (IGF-1) which mediates the characteristic somatic overgrowth and multisystem involvement observed in affected individuals. The primary objective of medical therapy for acromegaly is to normalize IGF-1 levels according to age and sex. 'Dosing our first participant in this Phase 1 study of MAR002 is a critical milestone for Marea Therapeutics and brings us closer to addressing the significant unmet needs of patients with acromegaly,' said Josh Lehrer, M.D., chief executive officer of Marea Therapeutics. 'We believe MAR002's unique properties, including an allosteric mechanism of action, could make it a differentiated and optimal medical therapy for acromegaly, increasing the effectiveness and reducing the burden associated with current therapies.' The MAR-201 study is a first-in-human (FIH), randomized, blinded, parallel-group, placebo-controlled single ascending dose (SAD) study in healthy men. Key objectives of the study include: Primary Objective: To evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002, assessed by treatment-emergent adverse events (TEAEs), vital signs, physical examinations, safety laboratories, and electrocardiograms (ECGs). Secondary Objective: To evaluate the pharmacokinetics (PK) of SC administration of MAR002 Exploratory Objectives: To evaluate the effect of SC administration of MAR002 on serum IGF-1 levels (pharmacodynamics [PD]/efficacy) and to assess the immunogenicity. About MAR002 MAR002 is a potent and selective half-life-extended, allosteric, human monoclonal growth hormone receptor antagonist (GHRA) antibody being developed for the treatment of acromegaly. The in vivo PK and PD properties of MAR002 are predictable and typical of a half-life extended human antibody, showing a long duration of action compatible with infrequent subcutaneous dose administration in humans. These characteristics support its potential to offer an effective and convenient treatment for patients with acromegaly. About Acromegaly Acromegaly is an orphan disease characterized by the excess secretion of growth hormone (GH) from a benign pituitary adenoma. Acromegaly affects approximately 30,000 patients in the U.S. If left untreated, acromegaly is highly morbid, leading to significant comorbidities such as GH-induced insulin resistance and diabetes, and serious cardiovascular pathology. The median lifespan of patients can be shortened by 10 years without effective therapy, and incomplete IGF-1 normalization is associated with increased mortality. Despite its severity, acromegaly is often under or misdiagnosed, with an average time from symptom onset to diagnosis of approximately eight years. The current treatment paradigm for acromegaly often involves surgery, performed in over 90% of patients, which achieves remission in about 50% of cases, though this can degrade over time. Medical therapy is required for approximately 65% (around 20,000 in the U.S.) of patients during their disease journey. Current medical treatments include somatostatin receptor ligands (SRLs) and growth hormone receptor antagonist (GHRA) pegvisomant. However, most patients do not achieve biochemical control with existing therapies. About Marea Therapeutics Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases. The company's lead therapy, MAR001, is in Phase 2 clinical development for adults with metabolic dysfunction and high risk for atherosclerotic cardiovascular disease. The company is also advancing MAR002 for the treatment of acromegaly. To learn more, please visit and follow us on LinkedIn and X.


New York Post
26 minutes ago
- New York Post
CDC shooter Patrick Joseph White broke 150 windows and fired 180 shots in Atlanta attack
NEW YORK — The man who attacked the CDC headquarters in Atlanta on Friday fired more than 180 shots into the campus and broke about 150 windows, with bullets piercing 'blast-resistant' windows and spattering glass shards into numerous rooms, according to information circulated internally at the agency. It may take weeks or even months to replace windows and clean up the damage, Centers for Disease Control and Prevention personnel said. A Georgia man who had blamed the COVID-19 vaccine for making him depressed and suicidal opened fire late Friday, killing a police officer. Advertisement 5 Community members leaving flowers at a memorial for David Rose, the police officer killed in the shooting at the the Center of Disease Control and Prevention headquarters in Atlanta on Aug. 11, 2025. REUTERS No one at CDC was injured. The shooter was stopped by CDC security guards before driving to a nearby pharmacy and opening fire late Friday afternoon, a law enforcement official has told the AP. The official wasn't authorized to publicly discuss the investigation and spoke on condition of anonymity. Advertisement The 30-year-old man, Patrick Joseph White, later died, but authorities haven't said whether he was killed by police or killed himself. U.S. Health Secretary Robert F. Kennedy Jr. toured the CDC campus on Monday. CDC security pointed out broken windows across multiple buildings, including the main guard booth, according to a U.S. Department of Health and Human Services statement. Advertisement HHS Deputy Secretary Jim O'Neill and CDC Director Susan Monarez accompanied him, according to the statement. Kennedy also visited the DeKalb County Police Department, where he met with the police chief. Later. He also met privately with the widow of the fallen officer, David Rose. Monarez posted a statement on social media Friday night that said at least four CDC buildings were hit in the attack. 5 Bullet holes seen in a windows at a CDC building. ERIK S LESSER/EPA/Shutterstock Advertisement 5 Police vehicles near Emory University and the CDC after the shooting on Aug. 8, 2025. REUTERS 5 A bullet hold in the door of a CVS pharmacy near the shooting in Atlanta. AP The extent of the damage became more clear during a weekend CDC leadership meeting. Two CDC employees who were told about what was discussed at the meeting described details to The Associated Press on condition of anonymity because they weren't authorized to reveal the information. Details also were also in an agency memo seen by an AP reporter. Building 21, which houses Monarez's office, was hit by the largest number of bullets. CDC officials did not say if her office was hit. CDC employees were advised to work from home this week. Kennedy issued a statement Saturday that said 'no one should face violence while working to protect the health of others,' and that top federal health officials were 'actively supporting CDC staff.' Advertisement 5 A poster set up for Officer David Rose at the scene of the shooting. REUTERS He did not speak to the media during his visit Monday. A retired CDC official, Stephan Monroe, said he worried about the long-term impact the attack would have on young scientists' willingness to go to work for the government. 'I'm concerned that this is this is going to be a generational hit,' said Monroe, speaking to a reporter near the corner where a poster had been set up in honor of Rose. Advertisement Kennedy was a leader in a national anti-vaccine movement before President Donald Trump selected him to oversee federal health agencies, and has made false and misleading statements about the safety and effectiveness of about COVID-19 shots and other vaccines. Years of false rhetoric about vaccines and public health was bound to 'take a toll on people's mental health,' and 'leads to violence,' said Tim Young, a CDC employee who retired in April. Dr. Jerome Adams, the U.S. surgeon general during President Donald Trump's first administration, said Sunday that health leaders should appreciate the weight of their words. 'We have to understand people are listening,' Adams told 'Face the Nation' on CBS. 'When you make claims that have been proven false time and time again about safety and efficacy of vaccines, that can cause unintended consequences.'

39 minutes ago
CDC union condemns vaccine misinformation after shooter blamed COVID vaccine for depression
A Georgia man who had blamed the COVID-19 vaccine for making him depressed and suicidal has been identified as the shooter who opened fire late Friday on the U.S. Centers for Disease Control and Prevention headquarters, killing a police officer. The 30-year-old suspect, who died during the attack, had also tried to get into the CDC's headquarters in Atlanta but was stopped by guards before driving to a pharmacy across the street and opening fire, a law enforcement official told The Associated Press on Saturday. The man, identified as Patrick Joseph White, was armed with five guns, including at least one long gun, the official said, speaking on condition of anonymity because of not being authorized to discuss the investigation publicly. A union representing workers at the CDC said the shooting was not random and 'compounds months of mistreatment, neglect, and vilification that CDC staff have endured." It demanded federal officials condemn vaccine misinformation, saying it was putting scientists at risk. Here's what to know about the shooting and the continuing investigation: Police say White opened fire outside the CDC headquarters in Atlanta on Friday, leaving bullet marks in windows across the sprawling campus. At least four CDC buildings were hit, Director Susan Monarez said on X. DeKalb County Police Officer David Rose was fatally wounded while responding. Rose, 33, a former Marine who served in Afghanistan, had graduated from the police academy in March. White was found on the second floor of a building across the street from the CDC campus and died at the scene, Atlanta Police Chief Darin Schierbaum said. The police chief added that 'we do not know at this time whether that was from officers or if it was self-inflicted.' The Georgia Bureau of Investigations said the crime scene was 'complex' and the investigation would take 'an extended period of time." The American Federation of Government Employees, Local 2883, said the CDC and leadership of the Department of Health and Human Services must provide a 'clear and unequivocal stance in condemning vaccine disinformation.' Such a public statement by federal officials is needed to help prevent violence against scientists, the union said in a news release. 'Their leadership is critical in reinforcing public trust and ensuring that accurate, science-based information prevails,' the union said. Fired But Fighting, a group of laid-off CDC employees, has said HHS Secretary Robert F. Kennedy Jr. is directly responsible for the villainization of CDC's workforce through "his continuous lies about science and vaccine safety, which have fueled a climate of hostility and mistrust.' Kennedy reached out to staff on Saturday, saying 'no one should face violence while working to protect the health of others.' In a statement provided Monday, HHS Communications Director Andrew Nixon said Kennedy 'has unequivocally condemned the horrific attack and remains fully committed to ensuring the safety and well-being of CDC employees.' Nixon added that Rose's 'sacrifice to protect the CDC on its darkest day will never be forgotten.' Thousands of people who work on critical disease research are employed on the campus. The union said some staff were huddled in various buildings until late at night, while more than 90 young children who were locked down inside the CDC's Clifton School. The union said CDC staff should not be required to immediately return to work after experiencing such a traumatic event. In a statement released Saturday, it said windows and buildings should first be fixed and made 'completely secure." 'Staff should not be required to work next to bullet holes,' the union said. 'Forcing a return under these conditions risks re-traumatizing staff by exposing them to the reminders of the horrific shooting they endured.' The union also called for 'perimeter security on all campuses' until the investigation is fully completed and shared with staff. White's father contacted police and identified his son as the possible shooter. The father said his son had been upset over the death of his dog and also had become fixated on the COVID-19 vaccine, according to the law enforcement official. A neighbor of White's told The Atlanta Journal-Constitution that White 'seemed like a good guy' but spoke with her multiple times about his distrust of COVID-19 vaccines in unrelated conversations. 'He was very unsettled, and he very deeply believed that vaccines hurt him and were hurting other people,' Nancy Hoalst told the Atlanta newspaper. 'He emphatically believed that.' But Hoalst said she never believed White would be violent: 'I had no idea he thought he would take it out on the CDC.'